225 related articles for article (PubMed ID: 15695826)
1. BetaIII-tubulin induces paclitaxel resistance in association with reduced effects on microtubule dynamic instability.
Kamath K; Wilson L; Cabral F; Jordan MA
J Biol Chem; 2005 Apr; 280(13):12902-7. PubMed ID: 15695826
[TBL] [Abstract][Full Text] [Related]
2. Microtubule dynamics, mitotic arrest, and apoptosis: drug-induced differential effects of betaIII-tubulin.
Gan PP; McCarroll JA; Po'uha ST; Kamath K; Jordan MA; Kavallaris M
Mol Cancer Ther; 2010 May; 9(5):1339-48. PubMed ID: 20442307
[TBL] [Abstract][Full Text] [Related]
3. Expression of class III beta-tubulin reduces microtubule assembly and confers resistance to paclitaxel.
Hari M; Yang H; Zeng C; Canizales M; Cabral F
Cell Motil Cytoskeleton; 2003 Sep; 56(1):45-56. PubMed ID: 12905530
[TBL] [Abstract][Full Text] [Related]
4. A beta-tubulin leucine cluster involved in microtubule assembly and paclitaxel resistance.
Gonzalez-Garay ML; Chang L; Blade K; Menick DR; Cabral F
J Biol Chem; 1999 Aug; 274(34):23875-82. PubMed ID: 10446152
[TBL] [Abstract][Full Text] [Related]
5. Mutations at leucine 215 of beta-tubulin affect paclitaxel sensitivity by two distinct mechanisms.
Wang Y; Yin S; Blade K; Cooper G; Menick DR; Cabral F
Biochemistry; 2006 Jan; 45(1):185-94. PubMed ID: 16388594
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of class I, II or IVb beta-tubulin isotypes in CHO cells is insufficient to confer resistance to paclitaxel.
Blade K; Menick DR; Cabral F
J Cell Sci; 1999 Jul; 112 ( Pt 13)():2213-21. PubMed ID: 10362551
[TBL] [Abstract][Full Text] [Related]
7. Altered beta-tubulin isotype expression in paclitaxel-resistant human prostate carcinoma cells.
Ranganathan S; Benetatos CA; Colarusso PJ; Dexter DW; Hudes GR
Br J Cancer; 1998 Feb; 77(4):562-6. PubMed ID: 9484812
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel resistance in cells with reduced beta-tubulin.
Wang Y; Cabral F
Biochim Biophys Acta; 2005 Jun; 1744(2):245-55. PubMed ID: 15950754
[TBL] [Abstract][Full Text] [Related]
9. Cloning and sequencing of human betaIII-tubulin cDNA: induction of betaIII isotype in human prostate carcinoma cells by acute exposure to antimicrotubule agents.
Ranganathan S; Dexter DW; Benetatos CA; Hudes GR
Biochim Biophys Acta; 1998 Jan; 1395(2):237-45. PubMed ID: 9473684
[TBL] [Abstract][Full Text] [Related]
10. Mutations in alpha- and beta-tubulin that stabilize microtubules and confer resistance to colcemid and vinblastine.
Hari M; Wang Y; Veeraraghavan S; Cabral F
Mol Cancer Ther; 2003 Jul; 2(7):597-605. PubMed ID: 12883031
[TBL] [Abstract][Full Text] [Related]
11. βIII-Tubulin is required for interphase microtubule dynamics in untransformed human mammary epithelial cells.
Bouchet BP; Puisieux A; Galmarini CM
Eur J Cell Biol; 2011 Oct; 90(10):872-8. PubMed ID: 21820201
[TBL] [Abstract][Full Text] [Related]
12. Mitotic centromere-associated kinesin (MCAK) mediates paclitaxel resistance.
Ganguly A; Yang H; Pedroza M; Bhattacharya R; Cabral F
J Biol Chem; 2011 Oct; 286(42):36378-84. PubMed ID: 21903575
[TBL] [Abstract][Full Text] [Related]
13. Intra-allelic suppression of a mutation that stabilizes microtubules and confers resistance to colcemid.
Wang Y; Veeraraghavan S; Cabral F
Biochemistry; 2004 Jul; 43(28):8965-73. PubMed ID: 15248754
[TBL] [Abstract][Full Text] [Related]
14. Taxol differentially modulates the dynamics of microtubules assembled from unfractionated and purified beta-tubulin isotypes.
Derry WB; Wilson L; Khan IA; Luduena RF; Jordan MA
Biochemistry; 1997 Mar; 36(12):3554-62. PubMed ID: 9132006
[TBL] [Abstract][Full Text] [Related]
15. Suppression of microtubule dynamics by discodermolide by a novel mechanism is associated with mitotic arrest and inhibition of tumor cell proliferation.
Honore S; Kamath K; Braguer D; Wilson L; Briand C; Jordan MA
Mol Cancer Ther; 2003 Dec; 2(12):1303-11. PubMed ID: 14707271
[TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines.
Ling YH; Jiang JD; Holland JF; Perez-Soler R
Mol Pharmacol; 2002 Sep; 62(3):529-38. PubMed ID: 12181429
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel-resistant human ovarian cancer cells undergo c-Jun NH2-terminal kinase-mediated apoptosis in response to noscapine.
Zhou J; Gupta K; Yao J; Ye K; Panda D; Giannakakou P; Joshi HC
J Biol Chem; 2002 Oct; 277(42):39777-85. PubMed ID: 12183452
[TBL] [Abstract][Full Text] [Related]
18. Suppression of microtubule dynamics by epothilone B is associated with mitotic arrest.
Kamath K; Jordan MA
Cancer Res; 2003 Sep; 63(18):6026-31. PubMed ID: 14522931
[TBL] [Abstract][Full Text] [Related]
19. The microtubule-stabilizing agent discodermolide competitively inhibits the binding of paclitaxel (Taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel, and inhibits the growth of paclitaxel-resistant cells.
Kowalski RJ; Giannakakou P; Gunasekera SP; Longley RE; Day BW; Hamel E
Mol Pharmacol; 1997 Oct; 52(4):613-22. PubMed ID: 9380024
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel-dependent mutants have severely reduced microtubule assembly and reduced tubulin synthesis.
Barlow SB; Gonzalez-Garay ML; Cabral F
J Cell Sci; 2002 Sep; 115(Pt 17):3469-78. PubMed ID: 12154077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
